262 |
Delivering the Outcomes You Demand with SAPIEN 3 |
Jeehoon Kang |
Apr. 12. 21 |
261 |
My Experience of TAVR Using Cusp Overlap View for Self-Expanding THV |
Cheol Woong Yu |
Apr. 12. 21 |
260 |
TAVR Failure Due to Structural Valve Degeneration |
Vinayak Bapat |
Apr. 12. 21 |
259 |
My Experience Focusing on Cusp Overlap View |
Ju Han Kim |
Apr. 12. 21 |
258 |
How to Reduce PPI Rate with Cusp Overlap Technique |
Hemal Gada |
Apr. 12. 21 |
257 |
Antiplatelets Only Sufficient: TAVR Antithrombotics Less is More |
George D. Dangas |
Apr. 12. 21 |
256 |
Transcatheter Mitral Valve Repair: Guideline Changes, Evidence Gaps and Future Directions |
Gregg W. Stone |
Apr. 12. 21 |
255 |
TAVR Long Journey: Chain of RCTs, Guideline Changes, and Future Directions |
Martin Bert Leon |
Apr. 12. 21 |
254 |
Functional MR - Percutaneous Treatment Considerations |
Samir R. Kapadia |
Apr. 12. 21 |
253 |
Coronary Access Post TAVI |
Danny Dvir |
Apr. 12. 21 |